Case File
efta-efta01108082DOJ Data Set 9OtherDS9 Document EFTA01108082
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01108082
Pages
4
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
1 oft
ACCLI SarTY HOME SLEEP TEST REPORT
provided
by NovaSorn"
Patient Name:
JEFFREY EPSTEIN
Test ID:
ORD-512625
Date of Birth:
01/20/1953
Dates of Study:
06/27/2014
Gender:
Male
Referring Clinician:
BRUCE MOSKOWITZ,
Height, Weight:
72.0 in, 200.0 lbs
Ordering Clinician:
BRUCE MOSKOWITZ,
SSN Number:
Interpreting Physician: Michael Coppola MD
FCCP
Symptoms
This 61 y/o Male was referred for the following complaints: Snoring, Excessive Daytime Sleepiness
BMI 27.12 inches, Neck Size Not provided, Epworth 16.00
Diagnosis: Moderate Obstructive Sleep Apnea (ICD-9: 327.23, ICD-10: G47.33)
Interpretation and Recommendation
`This study confirms the presence of physiologic events consistent with moderate obstructive sleep apnea
(OSA) with frequent hypopneas and apneas.
The diagnosis of obstructive sleep apnea syndrome requires the presence of historical data such as excessive
daytime sleepiness or witnessed snoring and apneas at night in addition to sleep recordings documenting a
significant level of sleep disordered breathing. This study confirms those criteria and treatment for sleep
apnea is indicated.
Auto-titrating CPAP (continuous positive airway pressure) or a CPAP titration would be appropriate. Other
effective treatments which may be considered are oral appliances and otolaryngeal evaluation for treatable
upper airway narrowing. Treatment would also include careful attention to proper sleep hygiene, weight
reduction if the BMI is elevated, avoidance of sleeping in the supine position and avoidance of alcohol
within four hours of bedtime. Specific treatment decisions should be tailored to each patient based upon the
clinical situation and all treatment options should be considered. The patient should be instructed to avoid
driving if sleepy and careful clinical follow up is needed to ensure that the patient's symptoms are
improving with therapy and that PAP adherence is supported and measured if prescribed.
Although different insurers have different requirements, as an example Medicare requires documentation
that the patient is utilizing PAP therapy at least 4 hours per night for 70% of the nights during a 30
consecutive day period. The PAP device automatically collects this data and your DME (Durable Medical
Equipment) provider can supply it to you.
Interpreting Physician Signature
Electronically signed by: Michael Coppola MD FCCP on Saturday June 28, 2014 at 03:28 PM [GMT]
JEFFREY EPSTEIN, ORD-512625
NovaSom Inc. 877-753-3776
EFTA01108082
Page 2 of 2
Description of Procedure:
This Sleep Apnea recording was performed utilizing a AccuSom Type III diagnostic device that
simultaneously recorded oral/nasal airflow, chest wall motion by impedance, oxygen saturation (Nonin
Pulse oximeter), heart rate, and snoring. The study took place over 1 nights.
Data
Total recorded time: 7.51 hours for 1 nights
Total recorded minutes: 451.00
Highest AHI 3% (AASM criteria): 16.7
Highest AHI 4% (Medicare Criteria): 15.5
Night 1 Sleep Time: 07:31 Start 21:18 Stop 5:18 AHI 3% = 16.7, AHI 4% = 15.5
Total number of events @ 3%: 126
Total number of events @ 4%: 117
Total number of apneas: 116
Total number of hypopneas @ 3% criteria: 10
Total number of hypopneas @ 4% criteria: 1
Oximetry
Oxygen saturation <90% for approximately: 0.4 minutes recorded time (0.1% of recorded time)
Oxygen saturation >90% for approximately: 478.5 minutes recorded time
Night 1 Oxygen desaturations <90%: 0.08% of recorded time
Average heart rate: 49 b/m
Lowest heart rate: 41 b/m
I attest that I have reviewed the raw data acquired in this study and confirm that the sleep study was
technically adequate, unless stated otherwise above, and sufficient to allow for my interpretation.
Interpreting Physician
Electronically signed by: Michael Coppola MD FCCP on Saturday June 28, 2014
Signature
at 03:28 PM [GMT]
Date
06/28/2014
Interpreting Physician Signature
Electronically signed by: Michael Coppola MD FCC? on Saturday June 28, 2014 at 03:28 PM [GMT]
JEFFREY EPSTEIN, ORD-512625
NovaSom Inc. 877-753-3776
EFTA01108083
NOVASOW SLEEP STUDY
Night 1
Patient Name: JEFFREY E EPSTEIN
Date of Birth: 01/20/1953
Test ID: 0RD-512625
Oi 90
80
X70
v)rn
Csi c 60
o g
(,)c 50
O2 Saturation (Top Plot
Snoring Sound Levels (Bottom Plot)
Apneas & Hypopneas
50 V
I
40
30
17,
a)
20
-J
10
0
25:18
A+H* Index (AHURDI**): 16.7
Study Duration: 7 hours 31 minutes
Date of Study: June 27, 2014
FIRST FOUR HOURS
V Obstructive Apnea
<> Unclassified Apnea
Hypopnea"
22:18
ca 90
2-
-ru 80
TO 3 70
rn
.c 60
0 E
is 50
O2 Saturation (Top Plot)
Snoring Sound Levels (Bottom Plot)
Apneas & Hypopneas
23:18
SECOND FOUR HOURS
00:18
01:18
Obstructive Apnea
Unclassified Apnea
1 Hypopnea"
50
7()
40
.
30
20
-J
10
01:18
V
02:18
3:18
04:18
05:18
OXYGEN SATURATION INFORMATION
Saturation
100-95%
94-90%
89-85%
84-80%
79-70%
<70%
# Drops
0
9
0
0
0
0
Time (HH:MM)
01:53
06:04
< 1 min
00:00
00:00
00:00
Lowest O2 Sat was 89% (> 1 time); a "Drop" is >= 3% 02 fall.
EVENT SUMMARY
Event type
Total# Events
Avg. Duration
Max. Duration
#Events/Hr.
Obstructive Apneas
113
35 sec
99 sec
15
Unclassified Apneas
3
32 sec
40 sec
0.4
Hypopneas *
10
30 sec
45 sec
1.3
Total # A+H *
126
16.7
*A hypopnea is defined as a 50% or more reduction in airflow for at least 10
seconds, accompanied by a decrease in blood oxygen saturation of at least 3%
**AHI/RDI = sum of the apneas and hypopneas divided by the number of hours in the study.
Copyright © 1997-2013 by NovaSom, Inc. All rights reserved. - NovaSom Study Viewer (8.2.1.0].
EFTA01108084
SLEEP STUDY SUMMARY
Patient Name: JEFFREY E EPSTEIN
Date of Birth: 01/20/1953
Test ID: ORD-512625
Physician: BRUCE MOSKOWITZ MD
Night #1
Jun 27 2014
Device start time
21:03
Study start time
21:18
Study end time
05:18
Total study duration
07:31
Disconnects: #
0
Disconnect: (min)
0
Invalid respiratory signals: #
5
Invalid respiratory signal: (min)
27
Invalid O2 signal: (min)
1
Apnea + Hypopnea Index (AHI/RDI**)
with >= 3% O2 desaturation
16.7
Total number of hypopneas
with >= 3% O2 desaturation
10
Apnea + Hypopnea Index (AHI/RDI**)
with >= 4% O2 desaturation
15.5
Total number of hypopneas
with >= 4% O2 desaturation
1
Apnea Index (Al)
15.4
Total number of apneas
116
Obstructive apneas
113
Unclassified apneas*
3
Lowest O2 saturation
Time of occurrence
time below 90% saturation
Heart Rate (bpm)
89%
> 1 time
0%
Minimum
41
Maximum
89
Average
49
Snoring/Respiration Noise
Time over 50dBa (HH:MM)
05:33
°A) time over 50dBa
74%
Maximum (dBa)
80.0
Average (dBa)
59.0
**
Unclassified apnea: apnea accompanied by a reduction in chest movement of greater than 90% compared to baseline movement.
AHI/RDI = sum of the apneas and hypopneas divided by the number hours in the study.
Copyright @ 1997-2013 by NovaSom. Inc. All rights reserved. - NovaSom Study Viewer [8.2.1.0),
EFTA01108085
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
877-753-3776Wire Ref
ReferringRelated Documents (6)
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.